Northern Trust
JSPR icon

Northern Trust’s Jasper Therapeutics JSPR Stock Holding History

Northern Trust’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.3K Hold
34,576
– – ﹤0.01% 4302
2025
Q4 		$63.3K Buy
34,576
+664
+2% +$1.33K ﹤0.01% 4231
2025
Q3 		$80.7K Sell
33,912
-996
-3% -$3.02K ﹤0.01% 4185
2025
Q2 		$194K Sell
34,908
-68,182
-66% -$336K ﹤0.01% 3945
2025
Q1 		$443K Sell
103,090
-1,277
-1% -$8.5K ﹤0.01% 3624
2024
Q4 		$2.23M Sell
104,367
-2,573
-2% -$53.6K ﹤0.01% 2961
2024
Q3 		$2.01M Buy
106,940
+77,641
+265% +$1.55M ﹤0.01% 3002
2024
Q2 		$665K Buy
29,299
+6,602
+29% +$158K ﹤0.01% 3400
2024
Q1 		$666K Buy
22,697
+7,206
+47% +$128K ﹤0.01% 3469
2023
Q4 		$122K Hold
15,491
– – ﹤0.01% 4060
2023
Q3 		$108K Hold
15,491
– – ﹤0.01% 3992
2023
Q2 		$212K Sell
15,491
-38
-0.2% -$565 ﹤0.01% 3806
2023
Q1 		$281K Buy
15,529
+13,383
+624% +$247K ﹤0.01% 3700
2022
Q4 		$10.4K Hold
2,146
– – ﹤0.01% 4569
2022
Q3 		$17K Hold
2,146
– – ﹤0.01% 4572
2022
Q2 		$41K Buy
2,146
+117
+6% +$3.33K ﹤0.01% 4460
2022
Q1 		$72K Hold
2,029
– – ﹤0.01% 4441
2021
Q4 		$159K Buy
+2,029
New +$190K ﹤0.01% 4278

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Northern Trust's JSPR Position: Q1 2026 in Review

Northern Trust held its Jasper Therapeutics (JSPR) position steady in Q1 2026 at 34,576 shares worth $30.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4302.

Northern Trust first reported a position in JSPR in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.23M in Q4 2024. 58 funds tracked by Wall St. Rank hold JSPR as of Q1 2026.

  • Northern Trust held 34,576 shares of Jasper Therapeutics worth $30.3K as of Q1 2026.
  • Northern Trust left its Jasper Therapeutics share count unchanged in Q1 2026.
  • Jasper Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4302 holding.
  • Northern Trust first reported a position in Jasper Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • Northern Trust's Jasper Therapeutics position peaked at $2.23M in Q4 2024.
  • 58 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.